Upperton Limited

Upperton Limited

Trading as: Upperton Pharma Solutions
#03833301 Active
B2bManufacturingServices

Upperton Pharma Solutions is a leading Contract Development and Manufacturing Organisation (CDMO) specializing in the development and manufacturing of pharmaceutical dosage forms. With over 25 years of experience, they provide tailored solutions from pre-clinical development to commercial manufacture.

Founded: 31/08/1999
Industries: Research and experimental development on biotechnology
Location: Nottingham

Products

  • Nasal Drug Products
  • Oral Dosage Forms
  • Pulmonary Drug Products

Services

  • Analytical Services
  • Clinical Manufacturing
  • Formulation Development
  • Preformulation Studies
  • Regulatory Support

Financial Snapshot

Last accounts made up to 30 June 2024
Next accounts due 31 March 2026 (10 months)
Cash in Bank £9.12m
↓ -48%
Total Liabilities £19.85m
↑ 1746%
Employees 69
↑ 123%

Directors

Role:
Director
Appointed:
11/08/2022
Nationality:
British
Age:
51 years
Role:
Director
Appointed:
11/04/2022
Nationality:
British
Age:
54 years
Role:
Ceo
Appointed:
31/08/1999
Nationality:
British
Age:
64 years

People with Significant Control

Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors
Notified On:
11/04/2022
Nationality:
United Kingdom
Jun 2023Jun 2022Jun 2021
Income Statement
Turnover
Export Revenue
Sales
Other Operating Income
Other Operating Items
Cost of Sales
Raw Materials & Consumables
Gross Profit
Admin Expenses
Other Operating Charges
Depreciation
R&D Expenses
Operating Profit
EBITDA
Financial Revenue
Financial Expenses
Financial Profit/Loss
Interest Paid
Extraordinary Revenue
Extraordinary Expenses
Net Extraordinary Items
Pre-Tax Profit
Tax
Profit After Tax
Retained Profit
Balance Sheet
Non-Current Assets
Intangible Assets
Tangible Fixed Assets
Other Non-Current Assets
Current Assets
Stock
Debtors
Cash in Hand
Other Current Assets
Called Up Share Capital
P&L Account Reserve
Shareholder Funds
Other Shareholder Funds
Provisions
Long Term Debt
Creditors (> 1 year)
Other Non-Current Liabilities
Short Term Debt
Creditors
Creditors (< 1 year)
Other Current Liabilities
Key Metrics
Net Assets
Net Current Assets
Total Assets Less Current Liabilities
Working Capital
Enterprise Value
Added Value
Cashflow Before D&A
Other Information
Staff Costs
Number of Employees
1 shareholder available
Shareholder 1
Shares:
Percentage:
Filing Date:
Shareholder 2
Shares:
Percentage:
Filing Date:
Shareholder 3
Shares:
Percentage:
Filing Date:

Charges

No charges registered

Properties

4 properties
Regions
1
Freehold
0
Leasehold
4
EAST MIDLANDS

Albert Einstein Centre, Nottingham Science & Technology Park, Nottingham (NG7 2TN)

Leasehold NG7 2TN
Added 02/03/2018 CITY OF NOTTINGHAM
EAST MIDLANDS

5 Beeston Business Park, Technology Drive, Beeston, Nottingham (NG9 1LA)

Leasehold NG9 1LA
Added 23/06/2022 BROXTOWE
EAST MIDLANDS

11 Beeston Business Park, Technology Drive, Beeston, Nottingham (NG9 1LA)

Leasehold NG9 1LA
Added 23/06/2022 BROXTOWE
0 issuances recorded

Total Amount Raised (Valid Issuances)

Shares Issued (Valid Issuances)

Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:
Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:

Grants

No grant information available

Group Structure

Government Council Contracts Beta

No council contracts found

Company Filings

04/04/2025 Accounts

Accounts With Accounts Type Full

12/07/2024 Confirmation Statement

Confirmation Statement With No Updates

27/03/2024 Accounts

Accounts With Accounts Type Total Exemption Full

12/03/2024 Officers

Appoint Person Secretary Company With Name Date

12/03/2024 Officers

Termination Secretary Company With Name Termination Date

17/07/2023 Confirmation Statement

Confirmation Statement With No Updates

29/03/2023 Accounts

Accounts With Accounts Type Audited Abridged